Tom M. Karsten

OLVG

Papers

2

Total Citations

101

H-Index

2

About

Tom M. Karsten is a leading figure in the field of hepatopancreatobiliary (HPB) surgery, with a focused research agenda on advancing minimally invasive techniques for complex pancreatic procedures. His major contributions center on the rigorous evaluation of robotic and laparoscopic pancreatoduodenectomy (PD), particularly through landmark studies that define the learning curve and safety of these approaches. Karsten’s work, including the highly cited LEOPARD-2 trial protocol (95 citations), has been instrumental in transitioning the field from observational enthusiasm to evidence-based practice, critically comparing minimally invasive to open PD. His recent comprehensive analysis of the first 1,000 robotic pancreatoduodenectomies in the Netherlands (2025) provides invaluable, real-world data on outcomes across the learning curve, offering a roadmap for safe implementation. With a career dedicated to improving surgical recovery and reducing morbidity, Karsten’s research directly shapes clinical guidelines and training standards for the next generation of HPB surgeons, solidifying his role as a key architect in the modern evolution of pancreatic surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
101
Total Citations
51
Avg Citations/Paper
🏆 Most Cited Paper
Minimally invasive versus open pancreatoduodenectomy (LEOPARD-2): study protocol for a randomized controlled trial
95 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 47
🏛 Institutions: OLVG

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago